BenedicteS

Researching coagulation and inflammation at Oslo University Hospital

[Eric Topol @EricTopol]

We know about the heart-brain and brain-gut interactive axis. Now there's the liver-heart:
A clotting factor (FXI) made in the liver protects the heart (unexpectedly) from failure
https://t.co/vG2cFlo0Jg
https://t.co/4BqeHEiMyu

[Centre for Thrombosis and Haemostasis Research OUS @CTHR_ous]

Antithrombin deficiency not detected by current assays - important new info regarding importance of sugar entities. Great collaboration: @ugedelamorbar Javier Corral @morange_pierre @psandset @UniOslo

https://t.co/d8yz7vcMA4!

[Centre for Thrombosis and Haemostasis Research OUS @CTHR_ous]

The importance of investigating the bone marrow microenvironment in precursor stages of myeloma.

See interview by @XueyanCui from our lab during the annual meeting of the @isth in London. @UniOslo @Oslounivsykehus

https://t.co/HxVVbkzNio

[BenedicteS @Stavik_B]

Takk for at jeg fikk komme @Labprat1!

[Labprat @Labprat1]

Lytt til vår nyeste episode! Vi har besøk av forsker Benedicte Stavik som gir oss et innblikk i blodsykdommenes verden🔬🩸https://t.co/IVxWIp3Z7Q @RIIM_UiO_OUS @Xiangus @GregersenIda @BellandMaria @Stavik_B

[Centre for Thrombosis and Haemostasis Research OUS @CTHR_ous]

In this paper Xueyan Cui in our lab shows that TFPI enhances CXCL12-mediated transendothelial migration of chronic lymphocytic leukemia cells by increasing the expression of the CXCL12 receptor CXCR7, possibly contributing to organ infiltration.

https://t.co/4BWkJTDvyS

[JTH @JTHjournal]

New accepted #COVID19 article shows #anticoagulant treatment is associated with decreased mortality in severe COVID-19 patients with coagulopathy. See here: https://t.co/rLBZvHwGAJ